Beam Therapeutics to Participate in Upcoming Investor Conferences 

Rhea-AI Summary

Beam Therapeutics (Nasdaq: BEAM) announced its participation in two upcoming investor conferences in August 2020. The company will be featured in the William Blair Biotech Focus Conference on August 6 at 1:00 p.m. ET, discussing 'Gene Editing and Gene Therapy in 2030.' Additionally, it will present at the Wedbush PacGrow Healthcare Virtual Conference on August 12 at 9:45 a.m. ET. Live webcasts of these events will be accessible on the investor section of Beam's website and archived for 60 days thereafter.

CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in the following August investor conferences:

• William Blair Biotech Focus Conference 2020 “Gene Editing and Gene Therapy in 2030” Panel on Thursday, Aug. 6, 2020 at 1:00 p.m. ET; and,
• 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 12, 2020 at 9:45 a.m. ET.

Live webcasts will be available in the investor section of the company's website at www.beamtx.com. The webcasts will be archived for 60 days following the presentations.

About Beam Therapeutics

Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. For more information, visit www.beamtx.com.

Contacts:

Investors:
Monique Allaire
THRUST Strategic Communications
monique@thrustsc.com

Media:
Dan Budwick
1AB
dan@1abmedia.com

FAQ

What conferences will Beam Therapeutics participate in August 2020?

Beam Therapeutics will participate in the William Blair Biotech Focus Conference on August 6 and the Wedbush PacGrow Healthcare Virtual Conference on August 12, 2020.

What is the focus of Beam's presentation at the William Blair Conference?

Beam's presentation at the William Blair Conference will focus on 'Gene Editing and Gene Therapy in 2030'.

Where can I find the webcast for Beam's conferences?

The live webcasts for Beam's conferences will be available in the investor section of their website, www.beamtx.com.

How long will the webcasts of Beam's presentations be available?

The webcasts of Beam's presentations will be archived for 60 days following the events.

What is the stock symbol for Beam Therapeutics?

The stock symbol for Beam Therapeutics is BEAM.